Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call Transcript May 15, 2025
Gossamer Bio, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.18.
Bryan Giraudo – COO & CFO:
Faheem Hasnain – Co-Founder, CEO, President & Chairman:
Richard Aranda – Chief Medical Officer:
Caryn Peterson – EVP, Regulatory Affairs:
Bob Smith – Chief Commercial Officer:
Q&A Session
Q1 2025MSN NewsNASDAQ:GOSSEarnings Call Transcript
